SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-19-005036
Filing Date
2019-04-30
Accepted
2019-04-30 16:31:50
Documents
5
Period of Report
2019-06-13
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF14A tgtx-def14a2019.htm DEF 14A 640917
2 IMAGE proxycard2019_page1.jpg GRAPHIC 88750
3 IMAGE proxycard2019_page2.jpg GRAPHIC 68900
4 IMAGE tgtx-def14a2019000.jpg GRAPHIC 3780
5 IMAGE tgtx-def14a2019001.jpg GRAPHIC 4925
  Complete submission text file 0001654954-19-005036.txt   861136
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 19782278
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1